6.
Castle P, Stoler M, Solomon D, Schiffman M
. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol. 2007; 127(5):805-15.
DOI: 10.1309/PT3PNC1QL2F4D2VL.
View
7.
Baldwin P, Laskey R, Coleman N
. Translational approaches to improving cervical screening. Nat Rev Cancer. 2003; 3(3):217-26.
DOI: 10.1038/nrc1010.
View
8.
Negri G, Bellisano G, Zannoni G, Rivasi F, Kasal A, Vittadello F
. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri. Am J Surg Pathol. 2008; 32(11):1715-20.
DOI: 10.1097/PAS.0b013e3181709fbf.
View
9.
Stoler M, Schiffman M
. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001; 285(11):1500-5.
DOI: 10.1001/jama.285.11.1500.
View
10.
Conesa-Zamora P, Domenech-Peris A, Orantes-Casado F, Ortiz-Reina S, Sahuquillo-Frias L, Acosta-Ortega J
. Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. Am J Clin Pathol. 2009; 132(3):378-90.
DOI: 10.1309/AJCPO0WY1VIFCYDC.
View
11.
Kruse A, Baak J, Helliesen T, Kjellevold K, Bol M, Janssen E
. Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia. Am J Surg Pathol. 2002; 26(11):1501-7.
DOI: 10.1097/00000478-200211000-00013.
View
12.
Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P
. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009; 35(3):210-20.
PMC: 2784486.
DOI: 10.1016/j.ctrv.2008.10.005.
View
13.
Pirog E, Baergen R, Soslow R, Tam D, DeMattia A, Chen Y
. Diagnostic Accuracy of Cervical Low-Grade Squamous Intraepithelial Lesions Is Improved With MIB-1 Immunostaining. Am J Surg Pathol. 2002; 26(1):70-5.
DOI: 10.1097/00000478-200201000-00008.
View
14.
Kalof A, Cooper K
. Our approach to squamous intraepithelial lesions of the uterine cervix. J Clin Pathol. 2006; 60(5):449-55.
PMC: 1994530.
DOI: 10.1136/jcp.2005.036426.
View
15.
Quade B, Yang A, Wang Y, Sun D, Park J, Sheets E
. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol. 2001; 80(1):24-9.
DOI: 10.1006/gyno.2000.5953.
View
16.
Williams G, Romanowski P, Morris L, Madine M, Mills A, Stoeber K
. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A. 1998; 95(25):14932-7.
PMC: 24553.
DOI: 10.1073/pnas.95.25.14932.
View
17.
Galgano M, Castle P, Atkins K, Brix W, Nassau S, Stoler M
. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010; 34(8):1077-87.
PMC: 2921638.
DOI: 10.1097/PAS.0b013e3181e8b2c4.
View
18.
Castle P, Cox J, Jeronimo J, Solomon D, Wheeler C, Gravitt P
. An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstet Gynecol. 2008; 111(4):847-56.
DOI: 10.1097/AOG.0b013e318168460b.
View
19.
Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U
. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001; 92(2):276-84.
DOI: 10.1002/ijc.1174.
View
20.
Freeman A, Morris L, Mills A, Stoeber K, Laskey R, Williams G
. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res. 1999; 5(8):2121-32.
View